Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!

发布文献求助

Ethan

Lv3

334 积分 2023-08-12 加入

最近求助
最近应助
互助留言

KRAS Inhibition Activates an Actionable CD24 “Do Not Eat Me” Signal in Pancreatic Cancer 6天前 已完结
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway 6天前 已完结
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution 6天前 已完结
Drugging the undruggable RAS: Mission Possible? 6天前 已完结
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer 8天前 已完结
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model 8天前 已完结
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve is a Therapeutic Strategy for Pancreatic Cancer 8天前 已完结
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer 8天前 已完结
A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer 8天前 已完结
Therapeutic developments in pancreatic cancer 8天前 已完结

没有进行任何应助

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

Copyright © 2020-2026 AbleSci.COM, 科研通, All Right Reserved

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：821889395【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通